Advanced search
Publication Cover
The Aging Male Volume 13, 2010 - Issue 2
Submit an article Journal homepage
608
Views
21
CrossRef citations to date
0
Altmetric
Original Article

Solifenacin treatment in men with overactive bladder: effects on symptoms and patient-reported outcomes

Steven A. KaplanDepartment of Urology, Weill Cornell Medical College, New York, New York, USACorrespondence[email protected]
,
Evan R. GoldfischerHudson Valley Urology, Poughkeepsie, New York, USA
,
William D. SteersDepartment of Urology, University of Virginia School of Medicine, Charlottesville, Virginia, USA
,
Marc GittelmanSouth Florida Medical Research, Aventura, Florida, USA
,
Masakazu AndohAstellas Pharma US, Deerfield, Illinois, USA
&
Sergio Forero-SchwanhaeuserGlaxoSmithKline, King of Prussia, Pennsylvania, USA
Pages 100-107 | Received 21 Aug 2009, Accepted 23 Oct 2009, Published online: 10 Dec 2009

Citations (21)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Onder Canguven & Raidh Talib. (2020) Are We missing out the role of oxytocin in overactive bladder syndrome?. The Aging Male 23:5, pages 700-704.
Read now

Articles from other publishers (20)

Stavros Gravas, Mauro Gacci, Christian Gratzke, Thomas R.W. Herrmann, Markos Karavitakis, Iason Kyriazis, Sachin Malde, Charalampos Mamoulakis, Malte Rieken, Vasileios I. Sakalis, Natasha Schouten, Mark J. Speakman, Kari A.O. Tikkinen & Jean-Nicolas Cornu. (2023) Summary Paper on the 2023 European Association of Urology Guidelines on the Management of Non-neurogenic Male Lower Urinary Tract Symptoms. European Urology 84:2, pages 207-222.
Crossref
Mauro Gacci, Vasileios I. Sakalis, Markos Karavitakis, Jean-Nicolas Cornu, Christian Gratzke, Thomas R.W. Herrmann, Iason Kyriazis, Sachin Malde, Charalampos Mamoulakis, Malte Rieken, Natasha Schouten, Emma J. Smith, Mark J. Speakman, Kari A.O. Tikkinen & Stavros Gravas. (2022) European Association of Urology Guidelines on Male Urinary Incontinence. European Urology 82:4, pages 387-398.
Crossref
. 2022. Arzneimitteltherapie in der Palliativmedizin. Arzneimitteltherapie in der Palliativmedizin 887 900 .
Andrew Brown & Helena Burden. (2021) Lower urinary tract symptoms: initial management in men. Prescriber 32:6, pages 13-18.
Crossref
Arkadiusz Miernik & Christian Gratzke. (2020) Current Treatment for Benign Prostatic Hyperplasia. Deutsches Ärzteblatt international.
Crossref
Alex Gomelsky, Emily F. Kelly & Rebecca Budish. 2019. Contemporary Pharmacotherapy of Overactive Bladder. Contemporary Pharmacotherapy of Overactive Bladder 245 265 .
Nadir I. Osman, Reem Aldamanhori, Altaf Mangera & Christopher R. Chapple. (2016) Antimuscarinics, ?-3 Agonists, and Phosphodiesterase Inhibitors in the Treatment of Male Lower Urinary Tract Symptoms. Urologic Clinics of North America 43:3, pages 337-349.
Crossref
Mehmet Kaynar, Emre Altıntaş & Serdar Göktaş. (2016) Benign Prostat Hiperplazisi ve Antimuskarinik Tedavi. Anadolu Kliniği Tıp Bilimleri Dergisi 21:2, pages 163-163.
Crossref
Haitham Abdelmoteleb, Edward R. Jefferies & Marcus J. Drake. (2016) Assessment and management of male lower urinary tract symptoms (LUTS). International Journal of Surgery 25, pages 164-171.
Crossref
Y.-S. Lee, K.-S. Lee, J. C. Kim, S. Hong, B. H. Chung, C.-S. Kim, J. G. Lee, D. K. Kim, C. H. Park & J. K. Park. (2014) Persistence with solifenacin add-on therapy in men with benign prostate obstruction and residual symptoms of overactive bladder after tamsulosin monotherapy. International Journal of Clinical Practice 68:12, pages 1496-1502.
Crossref
Nadir I. Osman & Christopher R. Chapple. 2014. Male Lower Urinary Tract Symptoms and Benign Prostatic Hyperplasia. Male Lower Urinary Tract Symptoms and Benign Prostatic Hyperplasia 100 112 .
Maximilian Burger, Dietmar Betz, Christian Hampel & Monika Vogel. (2013) Efficacy and tolerability of solifenacin in men with overactive bladder: results of an observational study. World Journal of Urology 32:4, pages 1041-1047.
Crossref
Karl-Erik Andersson. 2014. Bladder Dysfunction in the Adult. Bladder Dysfunction in the Adult 121 222 .
Tomas L. Griebling. (2013) Overactive Bladder in Elderly Men: Epidemiology, Evaluation, Clinical Effects, and Management. Current Urology Reports 14:5, pages 418-425.
Crossref
Matthias Oelke, Alexander Bachmann, Aurélien Descazeaud, Mark Emberton, Stavros Gravas, Martin C. Michel, James N'Dow, Jørgen Nordling & Jean J. de la Rosette. (2013) EAU Guidelines on the Treatment and Follow-up of Non-neurogenic Male Lower Urinary Tract Symptoms Including Benign Prostatic Obstruction. European Urology 64:1, pages 118-140.
Crossref
Anastasios Athanasopoulos, Christopher Chapple, Clare Fowler, Christian Gratzke, Steven Kaplan, Christian Stief & Andrea Tubaro. (2011) The Role of Antimuscarinics in the Management of Men With Symptoms of Overactive Bladder Associated With Concomitant Bladder Outlet Obstruction: An Update. European Urology 60:1, pages 94-105.
Crossref
João Carlos Correia de Sa, Laura Airas, Emmanuel Bartholome, Nikolaos Grigoriadis, Heinrich Mattle, Celia Oreja-Guevara, Jonathan O’Riordan, Finn Sellebjerg, Bruno Stankoff, Karl Vass, Agata Walczak, Heinz Wiendl & Bernd C. Kieseier. (2011) Symptomatic therapy in multiple sclerosis: a review for a multimodal approach in clinical practice. Therapeutic Advances in Neurological Disorders 4:3, pages 139-168.
Crossref
S. A. Kaplan, C. G. Roehrborn, P. Abrams, C. R. Chapple, T. Bavendam & Z. Guan. (2011) Antimuscarinics for treatment of storage lower urinary tract symptoms in men: a systematic review. International Journal of Clinical Practice 65:4, pages 487-507.
Crossref
Anne K. Mongiu & Lori B. Lerner. (2010) Clinical Differences Between Solifenacin and Tolterodine. Current Bladder Dysfunction Reports 6:1, pages 1-6.
Crossref
. (2011) Current World Literature. Current Opinion in Urology 21:1, pages 84-91.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.